PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $922,886 | -23.4% | 30,081 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $1,205,346 | +23.7% | 30,081 | +26.0% | 0.01% | +25.0% |
| Q1 2023 | $974,584 | +144497.0% | 23,881 | +36.9% | 0.00% | +33.3% |
| Q4 2022 | $674 | -52.3% | 17,450 | -34.3% | 0.00% | -57.1% |
| Q3 2022 | $1,412 | -99.9% | 26,553 | +21.5% | 0.01% | +16.7% |
| Q2 2022 | $1,275,000 | +0.3% | 21,860 | +31.3% | 0.01% | +20.0% |
| Q1 2022 | $1,271,000 | +1.4% | 16,651 | -20.1% | 0.01% | 0.0% |
| Q4 2021 | $1,254,000 | +33.8% | 20,847 | +24.7% | 0.01% | +25.0% |
| Q3 2021 | $937,000 | -15.3% | 16,716 | -8.3% | 0.00% | 0.0% |
| Q2 2021 | $1,106,000 | +0.9% | 18,221 | +16.6% | 0.00% | 0.0% |
| Q1 2021 | $1,096,000 | +18.9% | 15,633 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $922,000 | -21.4% | 15,414 | -21.0% | 0.00% | -20.0% |
| Q3 2020 | $1,173,000 | -15.1% | 19,503 | -25.9% | 0.01% | -28.6% |
| Q2 2020 | $1,381,000 | +27.0% | 26,331 | -18.8% | 0.01% | +16.7% |
| Q1 2020 | $1,087,000 | -20.1% | 32,427 | +8.1% | 0.01% | 0.0% |
| Q4 2019 | $1,360,000 | +1871.0% | 30,010 | +1773.3% | 0.01% | – |
| Q4 2018 | $69,000 | – | 1,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |